A distinctive bullous skin reaction associated with enfortumab vedotin‐ejfv treatment for metastatic urothelial cancer: A case report. (16th November 2021) - Krause, Torben; Bonnekoh, Hanna; Dilling, Amrei; Nast, Alexander; Metz, Martin